Olema Pharmaceuticals Inc
OLMA
NASDAQ
Biotechnology
$10.63
USD
+0.12 (+1.14%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $919.60M
Volume 1.2M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
VOR | Vor Biopharma Inc | $1.25B | - | - | - | |
CGEM | Cullinan Therapeutics Inc | $1.18B | - | - | - | |
REPL | Replimune Group Inc | $1.15B | - | - | - | |
CRVS | Corvus Pharmaceuticals Inc | $1.14B | - | - | - | |
ODTX | Odyssey Therapeutics Inc | $1.07B | - | -19.0% | - | |
OLMA | Olema Pharmaceuticals Inc | $1.04B | - | - | - | |
AVTX | Avalo Therapeutics Inc | $1.04B | - | -86.6% | - | |
SANA | Sana Biotechnology Inc | $1.00B | - | - | - | |
ARDX | Ardelyx Inc | $996.75M | - | +16.8% | - |
Top Peer by Growth
Janux Therapeutics Inc
+5367.0% YoY Revenue
Best 1-Year Return
Climb Bio Inc
+793.8% Return